{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "CNY", "regularMarketChangePercent": -0.70671314, "regularMarketPrice": 44.96, "exchange": "SHH", "shortName": "DIZAL (JIANGSU) PHARMACEUTICAL ", "longName": "Dizal (Jiangsu) Pharmaceutical Co., Ltd.", "messageBoardId": "finmb_545155198", "exchangeTimezoneName": "Asia/Shanghai", "exchangeTimezoneShortName": "CST", "gmtOffSetMilliseconds": 28800000, "market": "cn_market", "marketState": "POSTPOST", "esgPopulated": false, "sharesOutstanding": 408151008, "bookValue": 4.319, "fiftyDayAverage": 48.462, "fiftyDayAverageChange": -3.5020027, "fiftyDayAverageChangePercent": -0.07226286, "twoHundredDayAverage": 40.02885, "twoHundredDayAverageChange": 4.9311485, "twoHundredDayAverageChangePercent": 0.12318986, "marketCap": 18350469120, "priceToBook": 10.409818, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "prevName": "Dizal (Jiangsu) Pharmaceutical Co., Limited", "nameChangeDate": "2023-05-09", "averageAnalystRating": "1.7 - Buy", "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1639099800000, "priceHint": 2, "regularMarketChange": -0.3199997, "regularMarketTime": 1683874803, "regularMarketDayHigh": 45.88, "regularMarketDayRange": "44.53 - 45.88", "regularMarketDayLow": 44.53, "regularMarketVolume": 730094, "regularMarketPreviousClose": 45.28, "bid": 44.95, "ask": 44.96, "fullExchangeName": "Shanghai", "financialCurrency": "CNY", "regularMarketOpen": 45.36, "averageDailyVolume3Month": 900051, "averageDailyVolume10Day": 811464, "fiftyTwoWeekLowChange": 22.189999, "fiftyTwoWeekLowChangePercent": 0.97452784, "fiftyTwoWeekRange": "22.77 - 56.12", "fiftyTwoWeekHighChange": -11.16, "fiftyTwoWeekHighChangePercent": -0.19885959, "fiftyTwoWeekLow": 22.77, "fiftyTwoWeekHigh": 56.12, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -1.82, "symbol": "688192.SS"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "199 Liangjing Rd", "address2": "Zhangjiang Hi-Tech Park Pudong District", "city": "Shanghai", "zip": "201203", "country": "China", "phone": "86 21 6109 7800", "fax": "86 21 5838 7361", "website": "https://www.dizalpharma.com", "industry": "Drug Manufacturers\u2014Specialty & Generic", "industryDisp": "Drug Manufacturers\u2014Specialty & Generic", "sector": "Healthcare", "longBusinessSummary": "Dizal (Jiangsu) Pharmaceutical Co., Ltd. discovers, develops, and commercializes medicines in the areas of cancer and immunological diseases. It develops Golidocitnib, which is in Phase II clinical trials for the treatment of hematological malignancy and immunological diseases; DZD8586 that is in Phase I for the treatment of hematological malignancy; Sunvozertinib, which is in Phase II clinical trials for the treatment of solid tumors; DZD1516 that is in Phase II clinical trials for the treatment of solid tumors; and DZD2269, which is in Phase I clinical trials for the treatment of solid tumors. The company was founded in 2017 and is based in Shanghai, China.", "fullTimeEmployees": 328, "companyOfficers": [{"maxAge": 1, "name": "Dr. Zhang  Xiaolin Ph.D.", "age": 57, "title": "GM, Chairman & Chief Scientist", "yearBorn": 1965, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Lyu  Hongbin M.B.A.", "age": 44, "title": "CFO, Board Sec. & Director", "yearBorn": 1978, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Zeng  Qingbei", "title": "Sr. VP & Chief Scientist", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Zhenfan  Yang M.D., Ph.D.", "age": 54, "title": "Deputy GM & Chief Medical Officer", "yearBorn": 1968, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Wu  Qingyi", "age": 48, "title": "Chief Commercial Officer", "yearBorn": 1974, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Chen  Susan", "title": "Sr. VP of Clinical Operation", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Tsui  Honchung", "title": "Sr. VP of Medicinal Chemistry", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Shih-Ying  Chang Ph.D.", "age": 59, "title": "Deputy GM & VP of Chemistry, Manufacturing and Control", "yearBorn": 1963, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Kan  Chen", "age": 48, "title": "VP", "yearBorn": 1974, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Violet  Zhang", "title": "VP of Operation", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "maxAge": 86400}}], "error": null}}